Ane R. Breivega


Ane has worked as a business lawyer since 2000. Her background includes practicing as an attorney in various commercial law firms, and as legal director and member of the management team both within the pharmaceutical industry and in a listed company engaged in oil-related activity.  

Ane has broad expertise within business law. She has assisted both private and public entities with contract negotiations, acquisitions, and other corporate law transactions as well as dispute handling. Ane has special expertise in intellectual property law, with particular emphasis on trademark law, copyright, employee inventions, and EU/EEA law.

She has industry knowledge of the pharmaceutical industry and has in-depth knowledge of the many special rules that follow from EU/EEA law, Norwegian regulations, and the industry regulations in Norway.

Furthermore, Ane has extensive experience in the preparation and introduction of internal compliance programs.

Ane also has experience as head of various industry-specific self-judgment bodies, and as a board member in both private and publicly owned enterprises.

Practice

  • Partner in Lin Advokater AS from 2020

  • Partner in Breivega Advokatfirma AS from 2016 to 2020

  • Legal Director of Pfizer AS from 2010 to 2015

  • General Counsel in Reservoir Exploration Technology (RXT) ASA from 2008 to 2010

  • Associate in Advokatfirmaet BAHR from 2000 to 2008

 

Appointments

  • Chair of ViNordic's marketing board in Norway from 2019

  • Chair of the Council on Drug Information (“Rådet”) from 2017

  • Board member of Vestre Viken HF from 2020 to 2022

  • Board member of Bane NOR SF from 2016 to 2021

  • Board member of Ruter AS from 2012 to 2016

  • Board member of Pfizer AS from 2010 to 2015

  • Member of the Law Centre's Committee for Life Science from 2012 to 2015

Education

  • Equality and Anti-Discrimination Law JUS5590, University of Oslo, 2015

  • Cand. jur., University of Bergen, 1999

  • Cand. mag., University of Bergen, 1993